Why the study?
Do high-risk ECG markers predict the risk of ventricular arrhythmic events, ICD shock, and sudden cardiac death in patients with arrhythmogenic right ventricular cardiomyopathy?
Do high-risk ECG markers predict the risk of ventricular arrhythmic events, ICD shock, and sudden cardiac death in patients with arrhythmogenic right ventricular cardiomyopathy?
High-risk ECG markers, particularly the extension of T-wave inversion in inferior leads, significantly predict ventricular arrhythmic events and sudden cardiac death in ARVC patients, enhancing current risk stratification models.
Answers are grounded in this paper and cite their sources.
Supports ECG markers for ARVC risk models; leaves open prospective validation before guiding therapy.
INTRODUCTION: Several investigations have shown that existing risk stratification processes remain insufficient for stratifying sudden cardiac death risk in arrhythmogenic right ventricular cardiomyopathy (ARVC). Multiple auxiliary parameters are investigated to offer a more precise prognostic model. Our aim was to assess the association between several ECG markers (epsilon waves, prolonged terminal activation duration (TAD) of QRS, fragmented QRS (fQRS), late potentials on signal-averaged electrocardiogram (SA-ECG), T-wave inversion (TWI) in right precordial leads, and extension of TWI in inferior leads) with the risk of developing poor outcomes in ARVC. METHODS: A systematic literature search from several databases was conducted until September 9th, 2023. Studies were eligible if it investigated the relationship between the ECG markers with the risk of developing ventricular arrhythmic events. RESULTS: This meta-analysis encompassed 25 studies with a total of 3767 participants. Our study disclosed that epsilon waves, prolonged TAD of QRS, fQRS, late potentials on SA-ECG, TWI in right precordial leads, and extension of TWI in inferior leads were associated with the incremental risk of ventricular arrhythmias, implantable cardioverter-defibrillator shock, and sudden cardiac death, with the risk ratios ranging from 1.46 to 2.11. In addition, diagnostic test accuracy meta-analysis stipulated that the extension of TWI in inferior leads had the uppermost overall area under curve (AUC) value amidst other ECG markers apropos of our outcomes of interest. CONCLUSION: A multivariable risk assessment strategy based on the previously stated ECG markers potentially enhances the current risk stratification models in ARVC patients, especially extension of TWI in inferior leads.
No takes yet. Share an insight, caveat, or question.
Iqbal et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: